Eikon Therapeutics, Inc. Common Stock (EIKN)

Eikon Therapeutics, Inc. Common Stock (EIKN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $408M; returns 1 day -11.9%, 1 week -2.2%.

Eikon Therapeutics (EIKN) is a late-stage clinical biopharmaceutical company that officially debuted on the Nasdaq in February 2026, marking one of the year's largest and most significant biotech IPOs.

Groups EIKN belongs to

• Biotechnology
• Biopharmaceutical
• Recent IPOs
• Clinical Stage Biotech
• Life Sciences
• Oncology
• Drug Discovery
• Artificial Intelligence
• Healthcare Innovation
• Cancer Therapeutics
• Automation
• R&D

EIKN financial model: income statement, cash flow and balance sheet